Bone grafting is a procedure used in dentistry to increase the density and volume of natural jawbone tissue. Natural bone grows and eventually completely replaces the graft material. Natural bone grafts such as allografts consists of demineralized bone matrix, which has better osteoconductive and osteoinductive activity. Moreover, synthetic bone grafts include grafts made of ceramic, composite, polymer, and bone morphogenetic proteins (BMPs). Furthermore, another essential product is dental membrane, which is often used for treatment of periodontal diseases and other oral health issues.
Key players in the market are focused on adopting strategies such as partnerships and acquisitions to expand their product portfolio and geographical positioning in the U.S. dental membranes and bone graft substitutes market. For instance, in June 2020, Geistlich Biomaterials announced expansion of their portfolio of regenerative and complimentary products through a new distribution partnership with Osteogenics Biomedical in the U.S. Furthermore, in September 2021, Straumann Group, a global provider of denture and orthodontic solutions, announced the establishment of a strategic partnership with Aspen Dental Management, Inc. (ADMI) to provide dental implant solutions to more than 1,000 ADMI affiliated offices across the U.S.
- This report provides an in-depth analysis of the U.S. dental membrane and bone graft substitutes market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the U.S. dental membrane and bone graft substitutes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical.,Medtronic, and OUSIA.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The U.S. dental membrane and bone graft substitutes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the U.S. dental membrane and bone graft substitutes market
-
- Dental Membrane
- Resorbable Membranes
- Non-resorbable Membranes
- Bone Graft Substitutes
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitute
-
- Collagen
- Hydrogel
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Polytetrafluoroethylene
- Human Cells Source
- Others
-
- Socket Preservation
- Ridge Augmentation
- Sinus Lifts
- Guided Bone Regeneration (GBR)
- Guided Tissue Regeneration (GTR)
-
- Hospitals
- Dental Clinics
- Others
-
- Institut Straumann AG
- Nobel Biocare Services AG
- Geistlich Pharma AG
- Zimmer Biomet Holdings, Inc.
- Dentsply Sirona, Inc.
- BioHorizons, Inc.
- NovaBone Products, LLC
- Collagen Matrix, Inc.
- Maxigen Biotech, Inc.
- Osteogenics Biomedical
- Medtronic
- OUSIA
